Community oncologists' perceptions and utilization of large-panel genomic tumor testing.

ABSTRACT:

Purpose

Large-panel genomic tumor testing (GTT) is an emerging technology with great promise but uncertain clinical value. Previous research has documented variability in academic oncologists' perceptions and use of GTT, but little is known about community oncologists' perceptions of GTT and how perceptions relate to clinicians' intentions to use GTT.

Methods

Community oncology physicians (N = 58) participating in a statewide initiative aimed at improving access to large-panel GTT completed surveys assessing their confidence in using GTT, attitudes regarding the value of GTT, perceptions of barriers to GTT implementation, and future intentions to use GTTs. Descriptive and multivariable regression analyses were conducted to characterize these perceptions and to explore the re

SUBMITTER: Anderson EC 

PROVIDER: S-EPMC8620967 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature